Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

H.C. Wainwright Global Life Sciences Conference
 Tuesday, March 9, 2021
 7:00am EST